Tumor-reactive CD8+T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide® ISA-51: Association with survival-Reference-Cited by-同舟云学术

Tumor-reactive CD8+T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide® ISA-51: Association with survival

Published:2009 Issue: Volume: Page:NA-NA
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Karbach Julia,Gnjatic Sacha,Bender Armin,Neumann Antje,Weidmann Eckhart,Yuan Jianda,Ferrara Cathy A.,Hoffmann Eric,Old Lloyd J.,Altorki Nasser K.,Jäger Elke

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference48 articles.

1. Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers;Jager;Proc Natl Acad Sci U S A,2000

2. Influence of antigen dose and costimulation on the primary response of CD8+ T cells in vitro;Cai;J Exp Med,1996

3. On the role of antigen in maintaining cytotoxic T-cell memory;Kundig;Proc Natl Acad Sci U S A,1996

4. Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination;Karbach;Int J Cancer,2007

5. A phase I trial of a recombinant vacinia virus expressing prostate-specific antigen in advanced prostate cancer;Eder;Clin Cancer Res,2000

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy;Clinical and Translational Medicine;2024-09

2. A phase 1 trial of human telomerase reverse transcriptase (hTERT) vaccination combined with therapeutic strategies to control immune-suppressor mechanisms;Experimental Biology and Medicine;2024-01-31

3. Vaccines: a promising therapy for myelodysplastic syndrome;Journal of Hematology & Oncology;2024-01-08

4. An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer;Cancer Control;2024-01

5. Rational design of adjuvants boosts cancer vaccines;Progress in Molecular Biology and Translational Science;2024